Biosyent Inc
XTSX:RX

Watchlist Manager
Biosyent Inc Logo
Biosyent Inc
XTSX:RX
Watchlist
Price: 12.1 CAD 0.67% Market Closed
Market Cap: 138.9m CAD

Operating Margin
Biosyent Inc

25.7%
Current
25%
Average
6.1%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
25.7%
=
Operating Profit
10.9m
/
Revenue
42.2m

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
CA
Biosyent Inc
XTSX:RX
136.3m CAD
26%
US
Eli Lilly and Co
NYSE:LLY
997.2B USD
44%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
3%
US
Johnson & Johnson
NYSE:JNJ
503.6B USD
27%
CH
Roche Holding AG
SIX:ROG
255.1B CHF
34%
UK
AstraZeneca PLC
LSE:AZN
209.4B GBP
24%
CH
Novartis AG
SIX:NOVN
206.2B CHF
33%
US
Merck & Co Inc
NYSE:MRK
244.4B USD
38%
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK
42%
IE
Endo International PLC
LSE:0Y5F
209B USD
11%
US
Pfizer Inc
NYSE:PFE
145.2B USD
29%
No Stocks Found

Biosyent Inc
Glance View

Market Cap
136.3m CAD
Industry
Pharmaceuticals

BioSyent, Inc. is a specialty pharmaceutical company, which engages in the development of pharmaceutical and healthcare products. The company is headquartered in Mississauga, Ontario. BioSyent, through its wholly owned subsidiaries BioSyent Pharma Inc. (BioSyent Pharma) and BioSyent Pharma International Inc., acquires or licenses and develops pharmaceutical and other healthcare products for sale in Canada and certain international markets. Hedley Technologies Ltd., a wholly owned subsidiary of BioSyent, operates in the non-chemical insecticide business. BioSyent products include Combogesic, Aguettant System, Cathejell, Cysview, FeraMAX 150, FeraMAX Powder, Proktis-M, RepaGyn, and TIBELLA. Combogesic is for the short-term management of mild to moderate acute pain and the reduction of fever in adults. Aguettant System are used for a variety of injectable medications in hospitals and the acute care setting. FeraMAX 150 is an oral hematinic indicated for the prevention and treatment of iron deficiency anemia. RepaGyn for the healing of the vaginal mucosa and the treatment of vaginal dryness.

RX Intrinsic Value
13.01 CAD
Undervaluation 7%
Intrinsic Value
Price
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
25.7%
=
Operating Profit
10.9m
/
Revenue
42.2m
What is the Operating Margin of Biosyent Inc?

Based on Biosyent Inc's most recent financial statements, the company has Operating Margin of 25.7%.

Back to Top